MedTrace Logo

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

NCT05791786 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-05-08

No results posted yet for this study

Summary

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

Conditions

  • Amniotic Fluid Embolism

Interventions

OTHER

Patient

affected individuals diagnosed with AFE

Sponsors & Collaborators

  • Amniotic Fluid Embolism (AFE) Foundation

    collaborator UNKNOWN

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Irene Stafford, MD · UT Health Science Center Health Science Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-05
Primary Completion
2031-10-01
Completion
2031-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05791786 on ClinicalTrials.gov